Gauff supports WTA gene-testing, criticizes its impact on the trans community
- Coco Gauff expressed understanding of the WTA Tour's new gene-testing policy.
- She criticized the politicization of the issue, which she believes fosters animosity towards the trans community.
- Gauff emphasized the need for a more nuanced conversation on the topic.
- The WTA's policy requires gene-testing for players competing in the 2028 Los Angeles Olympics.
- The testing focuses on the SRY gene, associated with male sex development.
Coco Gauff understands the reasoning behind the WTA Tour’s newly introduced gene-testing policy. However, she does not favor how politicized the discussion becomes in generating animosity towards the trans community.
Speaking to reporters at the Canadian Open in Toronto, Gauff provided what she called a nuanced answer following her opening-match win over Kayla Day. She stated, "So, yes, I guess I kind of agree with trying to protect the fairness in women’s sports. But I also do not like the attack that it is creating."
The Women’s Tennis Association introduced one-off mandatory gene-testing for all players as a requirement to compete at the 2028 Los Angeles Olympics. The testing focuses on the SRY gene, a segment of DNA typically found on the Y chromosome that indicates the presence of testes.
Gauff questioned the transparency of the introduction of the process, noting that some players only found out about the new policy when it was announced. The WTA stated that the policy distinguishes between biological sex and gender identity, asserting there is no intent to disrespect or question anyone's dignity.
高夫支持WTA基因检测，批评其对跨性别群体的影响
高夫表示理解WTA巡回赛新推出的基因检测政策的理由。然而，她不赞成这一讨论的政治化，认为这助长了对跨性别群体的敌意。
在多伦多的加拿大公开赛上，高夫在与凯拉·戴的首场比赛获胜后对记者表示，她提供了一个所谓的细致回答。她说：“所以，是的，我想我有点同意保护女性体育的公平性。但我也不喜欢这造成的攻击。”
女子网球协会推出了针对所有选手的单次强制基因检测，作为参加2028年洛杉矶奥运会的要求。检测主要关注SRY基因，这是通常在Y染色体上发现的一段DNA，表明睾丸的存在。
高夫质疑这一过程引入的透明度，指出一些选手在政策宣布时才得知新政策。WTA表示，该政策区分生物性别和性别认同，强调没有意图不尊重或质疑任何人的尊严。